Paolini John F. 的 Form 4 申報
Kiniksa Pharmaceuticals International, plc（KNSA），2023/12/11 申報
- 申報編號
- 0001415889-23-016183
- 申報時間
- 2023/12/11
- 交易日
- 2023/12/7
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 5 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $50.5 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Paolini John F.CIK 0001741533 | 高階主管（醫療長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/12/7 | Class A Common Share | M行使選擇權取得 | +28,600 | $1.86 | +$53,196 | 73,492 | 直接 | |
| 2023/12/7 | Class A Common Share | S賣出處分 | −7,380 | $17.54F2 | −$129,445.2 | 66,112 | 直接 | |
| 2023/12/7 | Class A Common Share | S賣出處分 | −13,017 | $17.64F3 | −$229,619.88 | 53,095 | 直接 | |
| 2023/12/7 | Class A Common Share | S賣出處分 | −6,702 | $17.75F4 | −$118,960.5 | 46,393 | 直接 | |
| 2023/12/7 | Class A Common Share | S賣出處分 | −1,501 | $17.81F5 | −$26,732.81 | 44,892 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/12/7 | Class A Common Shares | M行使選擇權處分 | −28,600 | $0.00 | $0 | 111,217 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $17.595. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.60 to $17.695. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.70 to $17.795. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.80 to $17.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
表 I 有 1 筆交易的價格引用這則附註。